XML 37 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
(LOSS) EARNINGS PER COMMON SHARE (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Numerators [Abstract]                      
Net (loss)/income $ (67,061) [1] $ 2,075 $ 4,664 [2] $ 1,837 [3] $ 951 [4] $ 5,639 $ 5,105 $ 4,792 $ (58,485) $ 16,487 $ 16,389
Denominators [Abstract]                      
Weighted average common shares - basic (in shares)                 12,607,833 11,701,607 11,559,895
Dilutive effect of restricted stock (in shares)                 0 137,575 181,618
Weighted average common shares - diluted (in shares)                 12,607,833 11,839,182 11,741,513
Basic earnings per share (in dollars per share) $ (5.31) [1] $ 0.16 $ 0.37 [2] $ 0.15 [3] $ 0.08 [4] $ 0.48 $ 0.44 $ 0.41 $ (4.64) $ 1.41 $ 1.42
Diluted earnings per share (in dollars per share) $ (5.31) [1] $ 0.16 $ 0.37 [2] $ 0.14 [3] $ 0.08 [4] $ 0.48 $ 0.43 $ 0.41 $ (4.64) $ 1.39 $ 1.40
Antidilutive securities excluded from computation of earnings per share (in shares)                 111,976    
[1] The fourth quarter of 2013 includes a goodwill impairment charge of $73,528 related to the Valent acquisition, $17,718 related to income tax valuation allowance, $2,620 related to a separation agreement reached with key members of Valent Aerostructures, LLC. and $453 of restructuring expenses related to the closure of the Precise Machine facility.
[2] The second quarter of 2013 includes a trade name impairment of $4,222 related to D3 Technologies offset by a contingent consideration write-off of $7,950 related to Valent.
[3] The first quarter 2013 includes $2,497 of non-recurring inventory step-up related to the Valent acquisition.
[4] The fourth quarter of 2012 includes $4,860 in acquisition fees related to Valent.